Delivery Order SPE2DB20D3104-SPE2DB25FW0E0
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of OxyContin ER 10 mg tablets (100-count units) with a contract ceiling value of $2,030.33. This non-set-aside award utilizes firm fixed price pricing and is scheduled for completion by September 15, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of OxyContin ER 20 mg tablets in quantities of 100 units. The contract is valued at $3,667.68 with a firm fixed-price structure and is scheduled for completion by August 6, 2025. This competitively awarded delivery order carries no set-aside designation and will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of OxyContin ER 20 mg tablets (100-count units) with a ceiling value of $4,339.26. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded procurement. The contract calls for ultimate completion by September 9, 2025, and the product will be delivered to AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of OxyContin ER 20 mg tablets in quantities of 100 per unit, with a ceiling value of $1,867.65. This firm fixed-price delivery order, which is not set-aside, is scheduled for completion by August 19, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for OxyContin ER 80 mg tablets in quantities of 100 units, with a ceiling value of $7,845.66. This is a firm fixed price delivery order with no set-aside designation, reflecting a competitive award to support federal medical supply needs. The order is scheduled for completion by September 11, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of OxyContin ER 20 mg tablets (100-count units) with a contract value of $2,783.05. This delivery order represents a firm fixed price, non-set-aside competitive award supporting federal medical procurement needs. The place of performance is located in Conshohocken, Pennsylvania, with an ultimate completion date of September 5, 2025. This delivery order is issued under...
- On September 12, 2025, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $6,544.19 to AmerisourceBergen Drug Corp for the supply of OxyContin ER 20 mg tablets (100-count units). The contract represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award. Performance will be completed by September 15, 2025, at the contractor's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for OxyContin ER 10 mg tablets (quantity 100s) with a ceiling value of $1,316.65. This firm fixed-price delivery order, issued on August 4, 2025, with an ultimate completion date of August 5, 2025, represents a competitive award with no set-aside designation. The point of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of OxyContin ER 10 mg tablets (100-count units) with a ceiling value of $2,098.96. This is a firm fixed price delivery order with an ultimate completion date of August 22, 2025, and represents a non-competitive set-aside contract. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of OxyContin ER 15 mg tablets (100-count units) with a ceiling value of $1,099.09. This competitively awarded, non-set-aside delivery order is priced on a firm fixed-price basis and is scheduled for completion by September 10, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The award represents a discrete delivery order fulfilling...
- SPE2DB20D3104Indefinite Delivery Contract
- SPE2DB20D3104-SPE2DB25FW0E0Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of OxyContin ER 10 mg tablets in quantities of 100 units. This firm fixed-price delivery order, valued at $1,955.66, is set to be completed by September 15, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was made on a non-set-aside basis, indicating open competitive procurement. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen serves the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through this comprehensive global pharmaceutical support vehicle. The IDC enables the company to supply an extensive range of brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains to support military healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 9/12/25 |